MedTrace Logo

Evaluation of Peripheral Blood Protein Biomarkers for Colorectal Cancer Screening

NCT05520840 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2026-02-06

No results posted yet for this study

Summary

The aim of the study is to validate the value of value of peripheral blood protein biomarkers in colorectal cancer screening, and to identify new ones

Conditions

Interventions

DIAGNOSTIC_TEST

blood sampling for screening of biomarkers

Patient aged 50 years or older referred for screening colonoscopy after a positive fecal immunochemical test or for endoscopic resection of a previously identified suspicious colorectal lesion will have a blood sampling for biomarkers detection

Sponsors & Collaborators

  • OncoDiag

    collaborator UNKNOWN

  • University Hospital, Caen

    collaborator OTHER

  • University Hospital, Rouen

    lead OTHER

Principal Investigators

  • Adrien Grancher, MD · University Hospital, Rouen

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-09
Primary Completion
2024-09-26
Completion
2024-09-26

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05520840 on ClinicalTrials.gov